Work

Real-world EGFR, ALK, and PD-L1 testing performance and end-to-end intervals in Colombian patients with non–small cell lung cancer.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.11091

Authors: Mateo Barros, Maria Paula Uchima-Vera, Manuela Estrada, Juliana Pardo, Ivan Triana, Isabella Gonzalez, Sara Chaves, Juliana Castro, Maria Meneses, Diana Canon, Margarita Baldion, Javier Segovia, Erick Andres Cantor, Henry Vargas, Luis Gerardo Garcia Hererros, Beatriz Wills

Institutions: Fundación Santa Fe de Bogotá, Universidad de Los Andes

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162501547

Cites:

Cited by:

Related to: